{"id":"W3172690078","doi":"10.1200/jco.2021.39.15_suppl.7011","title":"Venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with therapy-related myeloid neoplasms, antecedent myelodysplastic syndromes, or myelodysplastic/myeloproliferative neoplasms.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Azacitidine; Myelodysplastic syndromes; Internal medicine; Venetoclax; Hypomethylating agent; Gastroenterology; Decitabine; Ven; Oncology; Lenalidomide; Anagrelide; Chemotherapy; Essential thrombocythemia; Leukemia; Bone marrow; Polycythemia vera; Chronic lymphocytic leukemia; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007268951,0.0001752947,0.000836474,0.000176046,0.0001651279,0.0003643665,0.0002004222,0.0003759065,0.001715418],"category_scores_gemma":[0.0008737356,0.0001400141,0.0003883324,0.0003040797,0.0001899938,0.0002333166,0.0001468991,0.0006742249,0.0001932128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003336959,"about_ca_system_score_gemma":0.0004647384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005791315,"about_ca_topic_score_gemma":0.002613979,"domain_scores_codex":[0.9996845,0.0001680068,0.00002249548,0.00005684562,0.00003209402,0.00003608545],"domain_scores_gemma":[0.9995435,0.0001557772,0.0001478539,0.0000304783,0.00001572085,0.0001065945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5480539,0.01015058,0.1299366,0.001536286,0.00322406,0.0006553402,0.000358284,0.002569738,0.03427457,0.0005828133,0.004704918,0.2639529],"study_design_scores_gemma":[0.1845678,0.3913919,0.38574,0.0004042652,0.003152475,0.002400683,0.0002188347,0.002611189,0.005829697,0.0006444138,0.02299036,0.00004825325],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899703,0.006958292,0.0001685786,0.0001270976,0.00003867561,0.0002195193,0.0006117299,0.00001826703,0.001887563],"genre_scores_gemma":[0.9963837,0.001546189,0.0002710402,0.0001809787,0.00004330303,0.0001275941,0.0008453653,0.00000289582,0.0005988318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001715418,"threshold_uncertainty_score":0.005738676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05267757731609547,"score_gpt":0.3862507927842753,"score_spread":0.3335732154681798,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}